A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT02257372 · COMPLETED

Trial details

NCT number: NCT02257372
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2014-09-30
Primary completion: 2015-03-24
Enrollment: 236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.